| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Adar1 Capital Management, LLC is a 10% Owner at Rallybio Corporation with holdings across 3 companies. Recent SEC Form 4 filings include 11 buys and 3 sells.
Estimated insider holdings value: $26.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | RLYB Rallybio Corporation | 10% Owner | Buy | 155,905 | $13.97 | $2,178,668.31 | +7.8% | - | - | |
| Oct 15, 2025 | KROS Keros Therapeutics, Inc. | 10% Owner | Sell | 5,389,264 | $17.75 | $95,659,436.00 | -100% | +34.6% | - | |
| Apr 9, 2025 | KROS Keros Therapeutics, Inc. | 10% Owner | Buy | 934,258 | $10.13 | $9,464,512.25 | +5.9% | +34.7% | +20.9% | |
| Aug 12, 2024 | PVLA Palvella Therapeutics, Inc. | 10% Owner | Buy | 6,000 | $15.39 | $92,325.90 | +2.3% | +0.5% | +171.9% |